These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 526921)
1. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia. Chello PL; Sirotnak FM; Dorick DM; Moccio DM Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921 [TBL] [Abstract][Full Text] [Related]
2. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Chello PL; Sirotnak FM Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551 [TBL] [Abstract][Full Text] [Related]
3. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo. Bender RA; Nichols AP; Norton L; Simon RM Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia. Klubes P; Cerna I Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161 [TBL] [Abstract][Full Text] [Related]
6. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models. Sirotnak FM; Moccio DM; Dorick DM Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia. Wampler GL; Carter WH; Campbell ED; Goldman ID Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model. Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182 [TBL] [Abstract][Full Text] [Related]
10. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo. Chello PL; Sirotnak FM; Dorick DM Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407 [No Abstract] [Full Text] [Related]
11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Kim K; Blechman WJ; Riddle VG; Pardee AB Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice. Valeriote F; Vietti T; Coulter D J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994 [TBL] [Abstract][Full Text] [Related]
13. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia. Avery TL; Roberts D Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368 [TBL] [Abstract][Full Text] [Related]
14. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
16. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice. Warzocha K; Robak T Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside. Presant CA; Vietti TJ; Valeriote F; Coulter DM J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666 [TBL] [Abstract][Full Text] [Related]
18. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy. Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122 [TBL] [Abstract][Full Text] [Related]
19. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias. Ganu UK; Khandalekar DD; Gokhale SV Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126 [TBL] [Abstract][Full Text] [Related]
20. Effect of thymidine on the toxicity and antitumor activity of ftorafur. Grossie VB; Loo TL Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]